Reuters UK Business

Octopus Energy’s Bulb takeover faces legal challenge from rivals

By Sam Tobin (Reuters) – Collapsed British energy supplier Bulb’s acquisition by Octopus Energy faces further delays after rival suppliers E.ON, British Gas and Scottish Power told London’s High Court on Tuesday that they are mounting a legal challenge to the deal. Bulb, which had around 1.5 million domestic customers, was one of the largest …

Octopus Energy’s Bulb takeover faces legal challenge from rivals Read More »

German econ minister satisfied with 15-year LNG deal with Qatar

BERLIN (Reuters) – German Economy Minister Robert Habeck said on Tuesday he was happy with the 15-year term of a deal struck with Qatar to deliver liquefied natural gas (LNG) to Germany. “Fifteen years is great,” Habeck told a business conference in response to a reporter’s question. “I wouldn’t have had anything against 20 (years) …

German econ minister satisfied with 15-year LNG deal with Qatar Read More »

Hungary expects EU to approve its recovery plan next month: minister

BUDAPEST (Reuters) – Hungary’s government expects its recovery fund plan to be approved by EU finance ministers at an Ecofin meeting on Dec. 12, its minister in charge of EU negotiations said on Tuesday. The minister, Tibor Navracsics, also said he expects the European Commission will most probably recommend that EU governments suspend 65% of …

Hungary expects EU to approve its recovery plan next month: minister Read More »

Spain’s 12-month inflation slows down to 6.8% in November

(Reuters) – Spain’s consumer prices in the 12 months to November rose 6.8%, a slower pace than the previous 7.3% figure marked in October, preliminary data from the National Statistics Institute (INE) showed on Tuesday. The reading was the lowest since January and below the 7.4% forecast by analysts polled by Reuters. Core inflation, which …

Spain’s 12-month inflation slows down to 6.8% in November Read More »

AstraZeneca boosts cancer portfolio with $320 million Neogene deal

(Reuters) -AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, seeking to build its pipeline of cell-based cancer treatments. Though AstraZeneca’s oncology portfolio accounted for more than a third of the company’s revenue last year, it does not have an approved cell-based cancer therapy and is …

AstraZeneca boosts cancer portfolio with $320 million Neogene deal Read More »

Hopes of easing Chinese COVID curbs push FTSE 100 higher

(Reuters) – The commodity-heavy FTSE 100 rose on Tuesday with energy and mining stocks leading the rally and mirroring global gains as the possibility of less stringent COVID curbs in China helped lift investor sentiment. The blue-chip FTSE 100 was up 0.5%, tracking Asian and European peers, while the domestically-focused FTSE 250 midcap index slipped …

Hopes of easing Chinese COVID curbs push FTSE 100 higher Read More »

Close Bitnami banner
Bitnami